News >

Niraparib Approved in Europe for Ovarian Cancer

Jason Harris
Published: Wednesday, Nov 22, 2017

Mansoor Raza Mirza, MD

Mansoor Raza Mirza, MD
The European Commission has approved niraparib (Zejula) as a maintenance therapy for women with platinum-sensitive relapsed high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication